Bulletin 2011/31 - European Patent Office

(A61K) I.1(1)
(71) Merck Sharp & Dohme Corp., 126 East
Lincoln Avenue, Rahway, NJ 07065-0907,
US
(72) COX, Christopher, D., Rahway New Jersey
07065-0907, US
COLEMAN, Paul, J., Rahway New Jersey
07065-0907, US
BRESLIN, Michael, J., Rahway New Jersey
07065-0907, US
RAHEEM, Izzat, T., Rahway New Jersey
07065-0907, US
SCHREIER, John, D., Rahway New Jersey
07065-0907, US
ROECKER, Anthony, J., Rahway New Jersey
07065-0907, US
(74) Buchan, Gavin MacNicol, et al, Merck & Co.,
Inc. European Patent Department Hertford
Road, Hoddesdon, Hertfordshire EN11 9BU,
GB
(51) A61K 31/445 (11) 2 349 270 A1*
(25) En (26) En
(21) 09822447.0 (22) 15.10.2009
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK SM TR
(86) US 2009/060748 15.10.2009
(87) WO 2010/048013 2010/17 29.04.2010
(30) 21.10.2008 US 196856 P
(54) • 2,5-DISUBSTITUIERTE PIPERIDINOREXIN-
REZEPTOR-ANTAGONISTEN
• 2,5-DISUBSTITUTED MORPHOLINE
OREXIN RECEPTOR ANTAGONISTS
• ANTAGONISTES DE RÉCEPTEUR D ORE-
XINE DE MORPHOLINE 2,5-DISUBSTI-
TUÉE
(71) Merck Sharp & Dohme Corp., 126 East
Lincoln Avenue, Rahway, NJ 07065-0907,
US
(72) COX, Christopher, D., Rahway New Jersey
07065-0907, US
COLEMAN, Paul, J., Rahway New Jersey
07065-0907, US
FLORES, Broc, Rahway New Jersey 07065-
0907, US
SCHREIER, John, D., Rahway New Jersey
07065-0907, US
(74) Buchan, Gavin MacNicol, et al, Merck & Co.,
Inc. European Patent Department Hertford
Road, Hoddesdon, Hertfordshire EN11 9BU,
GB
A61K 31/445 → (51) A61K 31/135
A61K 31/445 → (51) C07D 211/96
A61K 31/4453 → (51) C07D 235/02
A61K 31/4523 → (51) C07D 407/06
A61K 31/455 → (51) A61K 31/195
A61K 31/46 → (51) C07D 451/02
A61K 31/47 → (51) A01N 43/42
A61K 31/47 → (51) C07D 215/28
A61K 31/47 → (51) C07D 215/54
A61K 31/47 → (51) C07D 235/02
A61K 31/47 → (51) C07D 401/12
(51) A61K 31/4706 (11) 2 349 271 A2*
(25) En (26) En
(21) 09740570.8 (22) 06.10.2009
Europäisches Patentblatt
European Patent Bulletin
Bulletin européen des brevets
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK SM TR
(86) US 2009/059730 06.10.2009
(87) WO 2010/042543 2010/15 15.04.2010
(30) 06.10.2008 US 102974 P
(54) • VERWENDUNG VON INHIBITOREN TOLL-
ÄHNLICHER REZEPTOREN BEI DER VOR-
BEUGUNG UND BEHANDLUNG VON
HYPERCHOLESTERINÄMIE UND HYPER-
LIPIDÄMIE UND DAMIT VERWANDTEN
KRANKHEITEN
• USE OF INHIBITORS OF TOLL-LIKE
RECEPTORS IN THE PREVENTION AND
TREATMENT OF HYPERCHOLESTEROLE-
MIA AND HYPERLIPIDEMIA AND DIS-
EASES RELATED THERETO
• UTILISATION D INHIBITEURS DE RÉCEP-
TEURS DU TYPE TOLL DANS LA PRÉ-
VENTION ET LE TRAITEMENT DE L
HYPERCHOLESTÉROLÉMIE ET DE L
HYPERLIPIDÉMIE ET DE MALADIES QUI Y
SONT ASSOCIÉES
(71) Idera Pharmaceuticals, Inc., 167 Sidney
Street, Cambridge, MA 02139, US
(72) ZHU, Fu-Gang, Bedford MA 01730, US
KANDIMALLA, Ekambar, Southboro MA
01772, US
AGRAWAL, Sudhir, Shrewsbury MA 01545,
US
(74) Schnappauf, Georg, et al, Dr. Volker Vossius
Patent- und Rechtsanwaltskanzlei Geibelstrasse
6, 81679 München, DE
A61K 31/4709 → (51) C07D 215/54
A61K 31/4709 → (51) C07D 401/12
A61K 31/4725 → (51) C07D 217/26
(51) A61K 31/473 (11) 2 349 272 A1*
A61K 31/48
(25) Fr (26) Fr
(21) 09783801.5 (22) 07.10.2009
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK SM TR
(86) EP 2009/063004 07.10.2009
(87) WO 2010/040765 2010/15 15.04.2010
(30) 07.10.2008 FR 0805544
(54) • TIERÄRZTLICHE ANTIPROLACTIN-
ZUSAMMENSETZUNG FÜR WIEDER-
KÄUER
• ANTIPROLACTINIC VETERINARY COMPO-
SITION FOR RUMINANTS
• COMPOSITION VETERINAIRE ANTIPRO-
LACTINIQUE DESTINEE AUX RUMINANTS
(71) CEVA Santé Animale SA, 10, avenue de la
Ballastière, 33501 Libourne Cedex, FR
(72) LAGARDE, Anouck, F-33270 Floirac, FR
FLOCH, Stephane, F-33133 Galgon, FR
BERTAIM, Thierry, F-33230 Coutras, FR
(74) Lecca, Patricia S., Cabinet Lecca 21 rue de
Fécamp, 75012 Paris, FR
A61K 31/4743 → (51) A61K 31/135
A61K 31/48 → (51) A61K 31/473
A61K 31/485 → (51) A61K 31/155
A61K 31/495 → (51) C07D 211/96
A61K 31/495 → (51) C07D 213/40
A61K 31/496 → (51) A61K 31/135
A61K 31/496 → (51) C07D 209/24
76
Anmeldungen
Applications
Demandes (31/2011) 03.08.2011
A61K 31/496 → (51) C07D 407/06
A61K 31/496 → (51) C07D 491/048
(51) A61K 31/497 (11) 2 349 273 A1*
C07D 403/00
(25) En (26) En
(21) 09825370.1 (22) 04.11.2009
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HR HU IE IS IT LI LT LU LV MC MK MT
NL NO PL PT RO SE SI SK SM TR
AL BA RS
(86) US 2009/063298 04.11.2009
(87) WO 2010/054006 2010/19 14.05.2010
(30) 04.11.2008 US 111251 P
22.06.2009 US 219341 P
(54) • MODULATOREN VON CXCR7
• MODULATORS OF CXCR7
• MODULATEURS DU CXCR7
(71) ChemoCentryx, Inc., 850 Maude Avenue,
Mountain View, California 94043, US
(72) CHEN, Xi, Palo Alto California 94301, US
FAN, Pingchen, Fremont California 94539,
US
GLEASON, Mark, M., Redwood City California
94061, US
JAEN, Juan, C., Burlingame California 94010,
US
LI, Lianfa, Palo Alto California 94306, US
MCMAHON, Jeffrey, P., Mountain View
California 94041, US
POWERS, Jay, Pacifica California 94044, US
ZENG, Yibin, Foster City California 94404, US
ZHANG, Penglie, Foster City California
94404, US
(74) Campbell, Patrick John Henry, et al, J.A.
Kemp & Co. 14 South Square Gray's Inn,
London WC1R 5JJ, GB
A61K 31/497 → (51) C07D 403/04
A61K 31/497 → (51) C07D 409/04
A61K 31/4985 → (51) C07D 513/04
A61K 31/4995 → (51) C07D 401/12
A61K 31/5025 → (51) A61K 31/155
A61K 31/5025 → (51) C07D 471/04
A61K 31/505 → (51) C07D 239/34
A61K 31/505 → (51) C07D 239/47
A61K 31/505 → (51) C07D 239/52
A61K 31/505 → (51) C07D 411/04
A61K 31/506 → (51) A61K 31/135
A61K 31/506 → (51) C07D 231/14
A61K 31/506 → (51) C07D 239/34
A61K 31/506 → (51) C07D 239/48
A61K 31/506 → (51) C07D 401/12
A61K 31/51 → (51) A61K 31/195
A61K 31/513 → (51) A61K 31/167
(51) A61K 31/517 (11) 2 349 274 A1*
A61P 11/06
(25) En (26) En
(21) 09815218.4 (22) 17.09.2009